Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
What Will Be the Growth Trajectory of the Atherosclerosis Drugs Market from 2024 to 2033?
In recent times, the market size of atherosclerosis drugs has consistently expanded. The market, poised to escalate from $48.72 billion in 2023 to $50.5 billion in 2024, will witness a compound annual growth rate (CAGR) of 3.6%. Contributory factors for this growth in the past included cholesterol regulation, blood pressure management, anti-smoking initiatives, research and development efforts as well as improvements in diagnostics.
Predictions indicate a consistent expansion in the atherosclerosis drugs market in the coming years. A surge to $57.03 billion by 2028 with a compound annual growth rate (CAGR) of 3.1% is anticipated. The projected rise over the forecast period is credited to the advent of novel therapies, precise medicinal treatments, inflammation therapy, and advancements in lipid management, along with regulatory backing. Key trends for this forecast period encompass biologic treatments, gene modification and gene treatment, combined treatments, customized treatment strategies, and the use of telemedicine and remote supervision.
Claim Your Free Sample of the Global Atherosclerosis Drugs Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12621&type=smp
What Are the Primary Growth Drivers for the atherosclerosis drugs Market?
The increase in cases of cardiovascular diseases anticipates fuelling the expansion of the atherosclerosis drug market. The term cardiovascular diseases encapsulates all the diseases impacting the heart and blood vessels, while atherosclerosis signifies the accumulation of fats, cholesterol, and other substances on a person’s artery walls. Atherosclerosis, defined by the buildup of plaque within the arteries, leads to cardiovascular diseases like coronary heart disease and stroke. Atherosclerosis drugs aim to treat these conditions by lessening the chances of complications and managing contributing factors like high cholesterol levels and blood clot formation. For example, a report from The Office for National Statistics, a UK government department, stated in March 2022 that between 2020 and 2021, heart attacks accounted for 19,440 to 20,061 deaths. Furthermore, the Centers for Disease Control and Prevention, an American public health agency, noted in May 2023 that 1 in 20 adults aged 20 years and above in the US suffer from cardiovascular diseases, with 695,000 cases and 375,476 deaths due to this condition recorded in 2021. Therefore, the widespread occurrence of cardiovascular diseases is predicted to bolster the atherosclerosis drug market.
What Are the Defining Segments of the Atherosclerosis Drugs Market?
1) By Drug Class: Anti-Platelet Medications, Fibric Acid And Omega-3 Fatty Acid Derivatives, Angiotensin-Covering Enzyme (ACE) Inhibitors, Diuretics, Cholesterol Lowering Medication, Beta Blockers, Calcium Channel Blockers, Other Drug Classes
2) By Route Of Administration: Oral, Injectable
3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, Other Distribution Channels
What Trends Are Revolutionizing Standards in the Atherosclerosis Drugs Market?
The prominence of product innovation is an emerging trend in the atherosclerosis drugs market. Leading corporations in this market are continually creating new drugs and seeking regulatory approval in order to maintain their market positioning. An example of this is Novartis AG, a pharmaceutical firm based in Switzerland. In December 2021, they received approval from the US Food and Drug Administration (FDA) for a pioneering siRNA drug named Leqvio (inclisiran) that lowers cholesterol levels and combats atherosclerotic cardiovascular disease. This groundbreaking drug, which comes in the form of a subcutaneous injection, decreases the quantity of LDL (low-density lipoproteins) cholesterol in the blood and is a treatment option for adults with clinical atherosclerotic cardiovascular disease. It represents a new alternative for patients whose LDL cholesterol objectives have not been met with other forms of therapy.
Order Now for Fast Delivery of Your Atherosclerosis Drugs Market Report!
https://www.thebusinessresearchcompany.com/report/atherosclerosis-drugs-global-market-report
What Regions Are Propelling Growth in the Atherosclerosis Drugs Industry?
North America was the largest region in the atherosclerosis drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the atherosclerosis drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The Atherosclerosis Drugs Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the atherosclerosis drugs market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Atherosclerosis Drugs Market Include
1. Atherosclerosis Drugs Market Executive Summary
2. Atherosclerosis Drugs Market Segments
3. Atherosclerosis Drugs Market Size And Template Market Growth Rate
4. Key Atherosclerosis Drugs Market Trends
5. Major Atherosclerosis Drugs Market Drivers
……
25. Key Mergers And Acquisitions In The Atherosclerosis Drugs Market
26. Top Atherosclerosis Drugs Companies
27. Atherosclerosis Drugs Market Opportunities And Strategies
28. Atherosclerosis Drugs Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
Central Nervous System Drugs Global Market Report 2022
https://www.thebusinessresearchcompany.com/report/central-nervous-system-drug-global-market-report
Drug Eluting Stent Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/drug-eluting-stent-global-market-report
Drugs for Immunotherapy Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
